Parvo Vaccine Inactivated Portsylis

Composition

Each dose of the vaccine (2 ml) contains at least 9 log2 GAE (haemagglutinating units) of the causative agent of parvovirus infection of pigs (strain PPV014) and an aqueous solution of α-tocopherol acetate, as an adjuvant.

Dosage form

Homogeneous aqueous suspension of white color.

Method of administration

For intramuscular injection.

The order of application

The vaccine is intended for active immunization of repairing sows and sows against parvovirus infection and erysipelas in well-off, conditionally-safe, endangered and dysfunctional farms.

Before use, the vials with vaccine are shaken thoroughly and heated in a water bath to a temperature of 30-36 ° C. When carrying out the vaccination, the rules of asepsis and antiseptics are observed. Use sterile syringes and needles, the injection site is disinfected with 70 ° C alcohol or other disinfectant solution.

Vaccinations are subject only to clinically healthy animals.

In order to prevent infections, the sows are vaccinated once, and the repair guinea pigs before the first insemination - twice with an interval of 4 weeks. The vaccine is administered intramuscularly behind the ear in a dose of 2 ml not later than 2 weeks before insemination.

Revaccination of animals is carried out 2-4 weeks before each insemination.

Side effect

Some animals may have post-vaccination reactions in the form of subfebrile fever, depression, loss of appetite, which disappear within 24 hours. It is also possible the formation of a slight swelling at the injection site, which disappears during the day.

The products of slaughter obtained from vaccinated animals are used without restrictions.

Form of issue

The vaccine is packaged in 20 ml (10 doses), 50 ml (25 doses) or 100 ml (50 doses) in glass bottles. Each bottle is packed in a cardboard box.

Storage conditions

Shelf life of the vaccine is 24 months from the date of manufacture, if stored at a temperature of 20C to 80C.